Safety of Cotrimoxazole in HIV- and HAART-exposed Infants

NCT01086878 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

222

Enrollment

OTHER

Sponsor class

Conditions

Acquired Immunodeficiency Syndrome
Infant, Newborn
Anemia
Neutropenia
HIV Infections

Interventions

DRUG: cotrimoxazole

Sponsor

Harvard School of Public Health (HSPH)

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]